Amgen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMGN Nasdaq 2836 www.amgen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amgen Inc.

UPS to build massive $6.1M cooler in Louisville. Here's what we know - Jan 21st, 2026 11:04 am
Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference - Jan 21st, 2026 7:02 am
Ember LifeSciences appoints Ann Hyllengren as Chief Financial Officer - Jan 21st, 2026 6:00 am
Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies - Jan 21st, 2026 5:11 am
Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.52 - Jan 21st, 2026 3:04 am
Nonprofit Health Services Organization Files Lawsuit Against Fortune 500 Pharmaceutical Company Over Prescription Drug Access - Jan 20th, 2026 9:34 am
A Look At Amgen (AMGN) Valuation After Strong Q3 Results And Pipeline Momentum - Jan 19th, 2026 6:07 pm
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - Jan 19th, 2026 1:23 pm
2 Dividend Stocks to Buy and Hold For 10 Years - Jan 19th, 2026 12:18 pm
CytomX Stock Rises 31% in a Month: Here's What You Should Know - Jan 19th, 2026 7:17 am
Beat the Market the Zacks Way: Amicus, Micron, Amgen in Focus - Jan 19th, 2026 6:01 am
Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now? - Jan 18th, 2026 10:30 am
Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 80% of the company - Jan 18th, 2026 5:00 am
Ahead of the Quantinuum IPO, Should You Buy Honeywell Stock? - Jan 16th, 2026 1:55 pm
Amgen’s Weight-Loss Drug Shows Promise With Less Frequent Dosing - Jan 15th, 2026 2:40 pm
Amgen Inc. (AMGN): A Bull Case Theory - Jan 15th, 2026 11:52 am
Amgen (AMGN) Advances While Market Declines: Some Information for Investors - Jan 14th, 2026 3:50 pm
Quantum Computing Stocks: Honeywell's Quantinuum Plans IPO - Jan 14th, 2026 6:41 am
Amgen Inc. (NASDAQ:AMGN) Shares Could Be 49% Below Their Intrinsic Value Estimate - Jan 14th, 2026 5:00 am
[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Jan 14th, 2026 1:30 am